Identification of c- MYC as a Target of the APC Pathway
Tong‐Chuan He, Andrew B. Sparks, Carlo Rago et al. · Science · 1998
The adenomatous polyposis coli gene (APC) is a tumor suppressor gene that is inactivated in most colorectal cancers. Mutations of APC cause aberrant accumulation of beta-catenin, which then binds T cell factor-4 (Tcf-4), causing increased transcriptional activation of unknown genes. Here, the c-MYC oncogene is identified as a target gene in this signaling pathway. Expression of c-MYC was shown to be repressed by wild-type APC and activated by beta-catenin, and these effects were mediated through Tcf-4 binding sites in the c-MYC promoter. These results provide a molecular framework for understanding the previously enigmatic overexpression of c-MYC in colorectal cancers.
Cited by 4,564 works. doi:10.1126/science.281.5382.1509
Authors
- Tong‐Chuan He
- Andrew B. Sparks
- Carlo Rago
- Heiko Hermeking
- Leigh S. Zawel
- Luís Teixeira da Costa
- Patrice J. Morin
- Bert Vogelstein
- Kenneth W. Kinzler
References
- Serial Analysis of Gene Expression
- Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
- Identification and characterization of the familial adenomatous polyposis coli gene
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
- Functional interaction of β-catenin with the transcription factor LEF-1
- Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line
- Characterization of the Yeast Transcriptome
- XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
- Association of the APC Gene Product with β-Catenin